MiR-15a suppresses hepatocarcinoma cell migration and invasion by directly targeting cMyb
1Oncology Center, Zhujiang Hospital of Southern Medical University Guangzhou 510282, Guangdong, China.
Purpose:
This study aimed to determine the function of miR-15a in HCC, and identify cMyb as a target of miR-15a.
Methods:
RNA expression was evaluated by quantitative real-time PCR (qRT-PCR). The effects of miR-15a or cMyb on HCC cells were evaluated by transwell migration assay and western blot analysis. CMyb, the predicted target, has been frequently verified by luciferase assay.
Results:
MiR-15a was markedly downregulated in sphere culture HCC cells by qRT-PCR. CMyb was predicted to be a potential target of miR-15a using bioinformatics analysis. This prediction has been frequently verified by luciferase assay and western blot. A positive correlation between cMyb and the migration ability of HCC cells was demonstrated by transwell assays. MiR-15a mimic suppressed cMyb expression to weaken HCC cell migration ability. On the other hand, miR-15a inhibitor upregulated cMyb and induced HCC cell migration.
Conclusion:
MiR-15a could suppress HCC progression through the repression of cMyb, making miR-15a a potential therapeutic target.
Insights
MicroRNA-15a (miR-15a) suppresses hepatocellular carcinoma (HCC) progression by targeting cMyb. This finding establishes miR-15a as a potential therapeutic target for HCC treatment.
Area of Science:
- Molecular Oncology
- MicroRNA Biology
- Hepatocellular Carcinoma Research
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with limited therapeutic options.
- MicroRNAs (miRNAs) play critical roles in cancer development and progression.
- Dysregulation of specific miRNAs, like miR-15a, is implicated in HCC pathogenesis.
Purpose of the Study:
- To investigate the functional role of miR-15a in hepatocellular carcinoma (HCC).
- To identify and validate cMyb as a direct molecular target of miR-15a.
- To explore the therapeutic potential of targeting the miR-15a/cMyb axis in HCC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for RNA expression analysis.
- Transwell migration assays to assess cell motility.
- Western blot analysis for protein expression.
- Luciferase reporter assays for target validation.
Main Results:
- MiR-15a was significantly downregulated in sphere culture HCC cells.
- Bioinformatics and luciferase assays confirmed cMyb as a direct target of miR-15a.
- Overexpression of miR-15a suppressed cMyb, reducing HCC cell migration, while inhibition of miR-15a increased cMyb and migration.
Conclusions:
- MiR-15a acts as a tumor suppressor in HCC by inhibiting cMyb expression.
- The miR-15a/cMyb pathway is a critical regulator of HCC cell migration and progression.
- MiR-15a represents a promising therapeutic target for hepatocellular carcinoma.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
MicroRNAs
MicroRNAs
Master Transcription Regulators


